Literature DB >> 19370919

Simultaneous quantification of seven major bufadienolides in three traditional Chinese medicinal preparations of chansu by HPLC-DAD.

Xiao Chi Ma1, Bao Jing Zhang, Xin Lan Xin, Shan Shan Huang, Sha Deng, Hou Li Zhang, Xiao Hong Shu, Yun Peng Diao, Jian Cui.   

Abstract

A high-performance liquid chromatographic method was applied to the determination of gamabufotalin, telocinobufagin, bufotalin, cinobufotalin, bufalin, cinobufagin and resibufogenin in three traditional Chinese medicinal preparations containing ChanSu. The compounds were separated on a YMC-C18 column (250 x 4.6 mm, 5 um) with a gradient of acetonitrile and 0.3% aqueous acetic acid (v/v) at a flow rate of 0.8 mL min(-1) and detected at 296 nm. Complete separation was obtained within 35 min for the seven bufadienolides. The calibration curves showed good linearity (r2 > 0.999) within the test range. The recovery was 95.5% - 105.9%. The assay could simultaneously determine seven major bufadienolides of the three Chinese medicinal preparations of ChanSu in 35 min. The results obtained suggested that the developed HPLC assay could be comprehensively utilized for the quality control of the three traditional Chinese medicinal preparations of ChanSu used in the clinic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370919

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  8 in total

Review 1.  Angel of human health: current research updates in toad medicine.

Authors:  Qian Yang; Xuanxuan Zhou; Meng Zhang; Linlin Bi; Shan Miao; Wei Cao; Yanhua Xie; Jiyuan Sun; Haifeng Tang; Ying Li; Qing Miao; Siwang Wang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.

Authors:  Qian Li; Chuanwu Jiang; Yan Wang; Minghua Wei; Huijin Zheng; Yanqi Xu; Xuegang Xu; Fengyu Jia; Kai Liu; Gang Sun; Jianhua Zang; Ping Mo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-10       Impact factor: 3.000

3.  Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells.

Authors:  Zhenlong Yu; Tao Li; Chao Wang; Sa Deng; Baojing Zhang; Xiaokui Huo; Bo Zhang; Xiaobo Wang; Yuping Zhong; Xiaochi Ma
Journal:  Oncotarget       Date:  2016-03-29

4.  Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer.

Authors:  Liyuan Zhang; Zhenlong Yu; Yan Wang; Xiaobo Wang; Lianru Zhang; Chao Wang; Qingxi Yue; Xun Wang; Sa Deng; Xiaokui Huo; Xiangge Tian; Shanshan Huang; Baojing Zhang; Xiaochi Ma
Journal:  Oncotarget       Date:  2016-11-22

5.  Bufadienolides from Venenum Bufonis Inhibit mTOR-Mediated Cyclin D1 and Retinoblastoma Protein Leading to Arrest of Cell Cycle in Cancer Cells.

Authors:  Huamei Chang; Juan Li; Yajun Cao; Tiantian Liu; Suofang Shi; Wenxing Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

6.  Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na⁺/K⁺-ATPase Profibrotic Signaling Pathways.

Authors:  David J Kennedy; Fatimah K Khalaf; Brendan Sheehy; Malory E Weber; Brendan Agatisa-Boyle; Julijana Conic; Kayla Hauser; Charles M Medert; Kristen Westfall; Philip Bucur; Olga V Fedorova; Alexei Y Bagrov; W H Wilson Tang
Journal:  Int J Mol Sci       Date:  2018-08-29       Impact factor: 5.923

7.  Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.

Authors:  Lu Liu; Yang Liu; Xiaojia Liu; Na Zhang; Genxiang Mao; Qingxuan Zeng; Mingxiao Yin; Danqing Song; Hongbin Deng
Journal:  Cancer Sci       Date:  2018-09-23       Impact factor: 6.716

8.  Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.

Authors:  Yu-Long Lan; Cheng Chen; Xun Wang; Jia-Cheng Lou; Jin-Shan Xing; Shuang Zou; Ji-Liang Hu; Wen Lyu; Bo Zhang
Journal:  Cell Prolif       Date:  2019-11-20       Impact factor: 6.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.